Judson Taylor
Chief Tech/Sci/R&D Officer at DIANTHUS THERAPEUTICS, INC.
Profile
Judson Taylor's current job is as the Head-Technical Operations at Dianthus Therapeutics, Inc. Mr. Taylor's former jobs include being the Vice President-Technical Operations at Radius Health, Inc. from 2018 to 2022, and the Vice President-Supply Chain at Synergy Pharmaceuticals LLC from 2015 to 2018.
Mr. Taylor's education includes an MBA degree from Temple University (Pennsylvania) and an undergraduate degree from The Pennsylvania State University.
Judson Taylor active positions
| Companies | Position | Start |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 10/09/2023 |
Former positions of Judson Taylor
| Companies | Position | End |
|---|---|---|
| RADIUS HEALTH, INC. | Chief Tech/Sci/R&D Officer | 30/04/2022 |
| SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 31/07/2018 |
Training of Judson Taylor
| Temple University (Pennsylvania) | Masters Business Admin |
| The Pennsylvania State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Judson Taylor
